Table 1.
Laboratory findings of patient on admission
| Trait | Value | Reference |
|---|---|---|
| Hemoglobin | 9.6 g/dL | 11.5–15.5 g/dL |
| White blood cells | 5000 mm3 | 4–11,000 mm3 |
| Platelets | 155,000 mm3 | 150,000–4,500,000 mm3 |
| CRP | 3.12 mg/L | < 6 mg/L |
| MCV | 78 fL | 76–96 fL |
| MCH | 29 pg | 27–32 pg |
| MCHC | 30 g/dL | 30–35 g/dL |
| PBF | Normocytic normochromic anemia | |
| Urine R/E | Unremarkable | |
| S. creatinine | 0.66 mg/dL | 0.5–1.2 mg/dL |
| SGPT | 23 IU | 10–40 IU |
| D-dimer | 0.35 g/L | < 0.5 g/L |
| APTT | 34 seconds | 32–40 seconds |
| ANA | Strongly positive, homogenous pattern on immunofluorescence | |
| Anti-ds-DNA | 185 Iu/mL (strongly positive) | < 30 Iu/mL |
| Anticardiolipin Ab | ||
| IgM | 2.35 U/mL | < 15 U/mL |
| IgG | 3.9 | |
| Antibeta 2 glycoprotein 1 antibody | ||
| IgM | 7.9 | |
| IgG | 8.5 U/mL | < 40 U/mL |
| Complement | ||
| C3 | 0.07 g/L | 0.9–1.8 g/L |
| C4 | 0.03 g/L | 0.2–0.5 g/L |
| p-ANCA | 1.91 U/mL (negative) | < 5 U/mL |
| c-ANCA | 2.32 U/mL (negative) | < 5 U/mL |
| S. TSH | 1.98 μIu/mL | 0.85–4.54 μIu/mL |
| FT4 | 1.12 ng/dL | 0.7–1.48 ng/dL |
| CSF study | Appearance—clear | |
| Cell count—lymphocyte 3 cumm | 0–5 cumm | |
| Protein—35.4 mg/dL | 15–45 mg/dL | |
| Glucose—3.42 mmol/L | 2.2–3.9 mmol/L | |
| Oligoclonal band—absent | ||
| Gram, AFB stain and culture—negative | ||
| S. anti-NMO Ab | 35.01 μ/mL | < 3 μ/mL (no detectable antibody) |
| S. electrolyte | ||
| Na+(sodium) | 137 mmol/L | 135–145 mmol/L |
| K+ (potassium) | 3.9 mmol/L | 3.5–5.5 mmol/L |
| Mg2+ (magnesium) | 1.89 mmol/L | 1.7–2.2 mmol/L |
| Ca2+ (calcium) | 10.2 mg/dL | 9–11 mg/dL |
APTT activated partial thromboplastin time, ANA antinuclear antibody, ANCA antineutrophilic cytoplasmic antibody, anti-NMO Ab antineuromyelitis optica antibody, CRP C-reactive protein, CSF cerebrospinal fluid, PBF peripheral blood film, TSH thyroid-stimulating hormone